Importance of inhaler-device satisfaction in asthma treatment: Real-world observations of physician-observed compliance and clinical/patient-reported outcomes-Reference-Cited by-同舟云学术

Importance of inhaler-device satisfaction in asthma treatment: Real-world observations of physician-observed compliance and clinical/patient-reported outcomes

Published:2011-02-10 Issue:3 Volume:28 Page:202-212
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Therapy

Author:

Small M.,Anderson P.,Vickers A.,Kay S.,Fermer S.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://www.springerlink.com/index/pdf/10.1007/s12325-010-0108-4

Reference20 articles.

1. Braman S. The global burden of asthma. Chest. 2006;130:4S–12S.

2. Masoli M, Fabian D, Holt S, et al. Global Initiative for Asthma (GINA) program: the global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy. 2004;59: 469–478.

3. Rabe KF, Vermeire PA, Soriano JB, et al. Clinical management of asthma in 1999: the Asthma Insight and Reality in Europe (AIRE) study. Eur Resp J. 2000;16:802–807.

4. GlaxoSmithKline. Asthma in America: a landmark survey. Available at: www.asthmainamerica.com . Accessed March 25, 2010.

5. Adachi M, Morikawa A, Ishihara K. Asthma insights and reality in Japan (AIRJ). Arerugi. 2002;51: 411–420

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The environmental burden of inhalation;European Journal of Pharmaceutical Sciences;2024-09

2. Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines;Cardiovascular Therapy and Prevention;2024-04-01

3. Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care;Clinical Drug Investigation;2024-01-10

4. Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes;Current Medical Research and Opinion;2023-11-17

5. Improved efficiency of daratumumab treatment of multiple myeloma adopting the subcutaneous route: A micro‐costing analysis in three Italian hematology centers;Cancer Medicine;2023-11-09